March 2, 2015


Pharmacists threaten to boycott Algerian medicines and protest

Pharmacists' Syndicate criticized the interventions and pressures that are practice by the trade directorates on pharmacists work, calling upon the Health Ministry to put an end to these practices, particularly since the medicines market is subject to the Health Ministry and not to the Trade Ministry.

Pharmacists' Syndicate official spokesman, Salaheddine Mennaa, told Echorouk, "Directorate of Trade has no right to monitor pharmacists"...

Continue Reading >

February 26, 2015


Kenyan Ministry of Health Selects GE Healthcare as a Strategic Partner to Support Healthcare Modernization Program

  • GE Healthcare announced as key technology partner for wide-scale radiology infrastructure modernization program aimed at transforming 98 hospitals across Kenya’s 47 counties via comprehensive, wing-to-wing solution package;
  • Part of the Kenyan Government’s Kshs 38 billion (%USD 420 million) healthcare transformation program - one of the largest of its kind in Africa – to deliver sustainable healthcare development, in line with its Vision 2030 Plan;
  • Underscores GE Healthcare’s ongoing commitment to serving as a strategic partner to the Government...

    Continue Reading >

February 26, 2015


Enjoy your Couture Smile from Dr. Michael Formenius

Dr. Michael Formenius, CEO and Clinical Director of Dr. Michael’s Dental Clinics, brings to the UAE his expertise in crafting individualized smiles. Couture Smile™ is the art of creating a smile that enhances the features of the face, while maintaining a beautiful balance in size, proportion, position, color and angulation of the teeth. It enhances the overall look of a person while at the same time, strengthening the surfaces of teeth that are continuously exposed to wear and tear.


Continue Reading >

February 25, 2015


Government lost 600 million ZDZ annually on unused drugs

Head of the Algerian Association of Pharmacies, Farid Ben Hamdine, called upon government, in a statement to Echorouk, to solve the problem of the distribution of medicines in hospitals across many areas of the country.

"All the necessary medicines are available, but it remained preserved on some medical authorities without others. With regards to the reduction of the imported medicines' bill which reached, during the first ten"...

Continue Reading >

February 25, 2015


Gore Global Registry for Endovascular Aortic Treatment Reaches 2,500 Enrolled Patients

W. L. Gore & Associates, Inc. (Gore) reports that more than 2,500 patients have been enrolled in the Gore Global Registry for Endovascular Aortic Treatment (GREAT).

The registry is part of Gore’s dedication to post-market surveillance and monitoring long-term device performance in an effort to improve clinical practice and patient outcomes. Since August 2010, GREAT has collected data on patients treated with the minimally invasive GORE®"......

Continue Reading >

February 24, 2015


Management Buy out of Synexus Backed by LDC; the Deal Will Enable It to Further Expand Its Global Network

  • Synexus has been acquired from Lyceum Capital with the backing of LDC
  • The deal will enable Synexus to further expand both its global network of clinical research centres - into the US, Asia and South America - and the range of therapy areas it focuses on.
  • Synexus’, the global leader in its field, contracted order book stands today at a record $216 million.

Today (Monday 23rd February 2015) Synexus, the world’s largest multi-national company dedicated to the recruitment and running"...

Continue Reading >

February 23, 2015


Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc.

Ferring Pharmaceuticals announced today that it has signed an agreement with CTCBIO Inc. of Seoul, South Korea to acquire rights to a novel oral drug delivery technology.

Ferring’s success in developing oral formulations for peptide drugs including the world’s first orally active peptide, desmopressin (MINIRIN®) and the fast dissolving lyophilisate (MINIRIN®"...

Continue Reading >

February 20, 2015


REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant.

The REVLIMID Marketing Authorisation has been updated to include"...

Continue Reading >

February 19, 2015


5th Emirates Diabetes Congress Discusses Latest Treatments and Studies

  • 5th Emirates Diabetes & Endocrine Congress inaugurated by H.H. Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance, and President of Dubai Health Authority
  • UAE stood on the 16th position at the end of 2014, in regards to prevalence of diabetes (IDF). EDS aligned to the UAE National Vision 2021 of reducing the prevalence of Diabetes from 19% to 16% and Reduce Childhood Obesity from 14% to 12% in 2021
  • UAE National Diabetes and Lifestyle Survey (2012-2015), revealed that the prevalence of total diabetes in UAE reached over 19% whereas...

    Continue Reading >

February 18, 2015


Ferring Pharmaceuticals acquires two phase III ready orthobiologic product candidates from BioSET

Ferring Pharmaceuticals announced today that it has acquired the assets of BioSurface Engineering Technologies, Inc. (BioSET), including two phase III ready orthobiologic product candidates designed to improve bone repair. The initial indications for AMPLEX® and PREFIX® to be investigated are fusion in foot/ankle and lumbar spine surgical procedures, respectively. Both products are based on a unique biomimetic peptide designed to enhance the body’s own natural mechanisms of bone repair.


Continue Reading >